Skip to main content

All News & Insights by taisho tag


Showing 1-1 of 1
Thought Leadership
November 20, 2020

Taisho’s commercial molecule Luseogliflozin has been granted patent in India after dismissal of 4-pre-grant oppositions

The patent application (6000/DELNP/2007) for the commercial compound Luseogliflozin was subject to four pre-grant opposition. The hearing u/s 25(1) held

Showing 1-1 of 1